G Dooms Selected Research

Vomiting

12/2001

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Dooms Research Topics

Disease

1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2014
1	Hemorrhage 01/2014
1	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2011
1	Pericarditis 09/2011
1	Alopecia (Baldness) 12/2001
1	Multiple Sclerosis 12/2001
1	Nausea 12/2001
1	Disease Progression 12/2001
1	Chronic Progressive Multiple Sclerosis 12/2001
1	Vomiting 12/2001

Drug/Important Bio-Agent (IBA)

1	N(4)-oleylcytosine arabinosideIBA 01/2014
1	Methylprednisolone FDA LinkGeneric 12/2001
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2001

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2014
1	Therapeutics 09/2011